Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet plus calcitriol versus calcitriol alone for severe secondary hyperparathyroidism in dialysis patients
IRCT20200218046533N1Phase 2Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in secondary hyperparathyroidism (SHPT) comparing Calcitriol alone with Cinacalcet plus calcitriol (2 arms). Primary endpoints: Change in parathyroid hormone, Change in serum phosphorus and 1 more. Started Jun 2020; status: completed.
02
Drugs
cinacalcetcalcitriol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on IRCT20200218046533N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200218046533N1.